Key facts
- This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jun 2024, 16:59.
Halley E. Gilbert - 03 Jun 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- Director
- Issuer ticker
- PCVX
- Reported as of
- 03 Jun 2024
- Net transaction value
- -$1,231,230
- SEC form
- 4
- Accepted by SEC
- 05 Jun 2024, 16:59:41 UTC
- Prior SEC filing
- 17 May 2024
- Next SEC filing
- 10 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ron A. Metzger, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 05 Jun 2024.
Change
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: -$1,231,230.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Options Exercise
- Transaction value
- $97,370
- Shares
- +18,200
- Change %
- +324%
- Price
- $5.35*
- Shares after
- 23,825
- Date
- 03 Jun 2024
- Ownership
- Direct
PCVX
transaction
Common Stock
Sale
- Transaction value
- $1,328,600
- Shares
- -18,200
- Change %
- -76%
- Price
- $73.00
- Shares after
- 5,625
- Date
- 03 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCVX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,200
- Change %
- -37%
- Price
- $0.000000
- Shares after
- 30,374
- Date
- 03 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,200
- Exercise price
- $5.35
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.
Footnote F2
Option is fully vested and exercisable.
Footnote F3
Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.